[Federal Register Volume 59, Number 228 (Tuesday, November 29, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-29345]


[[Page Unknown]]

[Federal Register: November 29, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE
 

Manufacturer of Controlled Substances; Registration

    By Notice dated September 21, 1994, and published in the Federal 
Register on September 28, 1994 (59 FR 49421), Nycomed Inc., formerly 
Sanofi Winthrop L.P., DBA Sterling Organics, 33 Riverside Avenue, 
Rensselaer, made application to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of Meperidine (9230), a 
basic class of controlled substance listed in Schedule II.
    No comments or objections have been received. Therefore, pursuant 
to Section 303 of the Comprehensive Drug Abuse Prevention and Control 
Act of 1970 and Title 21, Code of Federal Regulations, Sec. 1301.54(e), 
the Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic class of controlled 
substance listed above is granted.

    Dated: November 21, 1994.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 94-29345 Filed 11-28-94; 8:45 am]
BILLING CODE 4410-09-M